User menu

The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial

Bibliographic reference The IST-3 collaborative group ; Peeters, André. The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial. In: The Lancet, Vol. 379, no. 9834, p. 2352-2363 (2012)
Permanent URL http://hdl.handle.net/2078.1/123469